The emerging role of dipeptidyl peptidase 3 in pathophysiology
The FEBS Journal · 2023-05 · 290 (9) · 2246-2262
DOI: 10.1111/febs.16429 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FEBS Journal, online erschienen am 25.03.2022. Verfasst von Grazia Malovan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry, Graz University of Technology, Austria. Hauptthemen laut MEDLINE: Dipeptidyl-Peptidases and Tripeptidyl-Peptidases. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Austrian Academy of Sciences.
Abstract (Originalsprache)
Dipeptidyl peptidase 3 (DPP3), a zinc‐dependent aminopeptidase, is a highly conserved enzyme among higher animals. The enzyme cleaves dipeptides from the N‐terminus of tetra‐ to decapeptides, thereby taking part in activation as well as degradation of signalling peptides critical in physiological and pathological processes such as blood pressure regulation, nociception, inflammation and cancer. Besides its catalytic activity, DPP3 moonlights as a regulator of the cellular oxidative stress response pathway, e.g., the Keap1‐Nrf2 mediated antioxidative response. The enzyme is also recognized as a key modulator of the renin‐angiotensin system. Recently, DPP3 has been attracting growing attention within the scientific community, which has significantly augmented our knowledge of its physiological relevance. Herein, we review recent advances in our understanding of the structure and catalytic activity of DPP3, with a focus on attributing its molecular architecture and catalytic mechanism to its wide‐ranging biological functions. We further highlight recent intriguing reports that implicate a broader role for DPP3 as a valuable biomarker in cardiovascular and renal pathologies and furthermore discuss its potential as a promising drug target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biochemistry, Graz University of Technology, Austria.
- Department of Experimental and Clinical Medicine, University of Florence, Italy.
- Institute of Pharmacy, Freie Universität Berlin, Germany.
- 4TEEN4 Pharmaceuticals GmbH, Hennigsdorf, Germany.
- Department of Biology, ETH Zurich, Switzerland.
ORCID-Profile: Grazia Malovan, Bettina Hierzberger, Shalinee Jha, Peter Macheroux
Förderung
- Austrian Academy of Sciences
Zitieren
APA
Malovan, G., Hierzberger, B., Suraci, S., Schaefer, M., Santos, K., Jha, S., & Macheroux, P. (2023). The emerging role of dipeptidyl peptidase 3 in pathophysiology. The FEBS Journal, 290(9), 2246-2262. https://doi.org/10.1111/febs.16429
Vancouver
Malovan G, Hierzberger B, Suraci S, Schaefer M, Santos K, Jha S, et al. The emerging role of dipeptidyl peptidase 3 in pathophysiology. The FEBS Journal. 2023;290(9):2246-2262. doi:10.1111/febs.16429
BibTeX
@article{Malovan2023,
author = {Malovan, Grazia and Hierzberger, Bettina and Suraci, Samuele and Schaefer, Maximilian and Santos, Karine and Jha, Shalinee and Macheroux, Peter},
title = {The emerging role of dipeptidyl peptidase 3 in pathophysiology},
journal = {The FEBS Journal},
year = {2023},
volume = {290},
number = {9},
pages = {2246--2262},
doi = {10.1111/febs.16429}
}
EUVIMED